Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification.

Abstract excerpt

Neuroblastoma is a heterogeneous tumor and that may have a favorable or unfavorable prognosis. In Japan, a nation-wide neuroblastoma mass-screening (MS) project assessed 6-month-old infants between 1985 and 2003, and almost all neuroblastomas, including regressing or maturing tumors were thought to be detected in this period. To evaluate the heterogeneity of neuroblastoma subgroups, we analyzed patients with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age Distribution
• Share to Incidence